Corrigendum to "IL-32 aggravates metabolic disturbance in human nucleus pulposus cells by activating FAT4-mediated Hippo/YAP signaling" [Int. Immunopharmacol. 141 (2024) 112966]
- PMID: 39294029
- DOI: 10.1016/j.intimp.2024.113049
Corrigendum to "IL-32 aggravates metabolic disturbance in human nucleus pulposus cells by activating FAT4-mediated Hippo/YAP signaling" [Int. Immunopharmacol. 141 (2024) 112966]
Erratum for
-
IL-32 aggravates metabolic disturbance in human nucleus pulposus cells by activating FAT4-mediated Hippo/YAP signaling.Int Immunopharmacol. 2024 Nov 15;141:112966. doi: 10.1016/j.intimp.2024.112966. Epub 2024 Aug 22. Int Immunopharmacol. 2024. PMID: 39178518
Publication types
LinkOut - more resources
Full Text Sources
